Klarskov P, Gerstenberg T C, Hald T
Scand J Urol Nephrol. 1986;20(1):41-6. doi: 10.3109/00365598609024478.
Twenty consecutive female patients with urge incontinence and stable detrusor function on provocative rapid fill CO2-cystometry were treated as out-patients with a bladder training programme and with terodiline/placebo in a double-blind cross-over design. Frequency and incontinence episodes decreased significantly, while first sensation and cystometric bladder capacity increased. Both objectively and subjectively terodiline was significantly better than placebo with 50% (95% confidence limits 18-82) more patients improved on terodiline than on placebo. Thirty percent of the patients (95% confidence limits 12-54) relapsed after withdrawal of terodiline. At 3 months follow-up the remaining 70% were satisfied with the outcome of the training programme. Side effects were mild and reversible. Serum creatinine and alkaline phosphatase increased slightly on terodiline and the diastolic blood pressure was probably also increased by terodiline. In conclusion, female patients with idiopathic urge incontinence and stable detrusor function did respond to treatment as do female patients with urge incontinence and proven instability.
20名连续的急迫性尿失禁女性患者,在激发性快速充盈二氧化碳膀胱测压法中逼尿肌功能稳定,作为门诊患者接受膀胱训练计划,并采用特罗地林/安慰剂双盲交叉设计进行治疗。排尿频率和尿失禁发作次数显著减少,而首次感觉和膀胱测压膀胱容量增加。客观和主观上,特罗地林均显著优于安慰剂,使用特罗地林治疗后病情改善的患者比使用安慰剂的多50%(95%置信区间18 - 82)。30%的患者(95%置信区间12 - 54)在停用特罗地林后复发。在3个月的随访中,其余70%的患者对训练计划的结果感到满意。副作用轻微且可逆。使用特罗地林后血清肌酐和碱性磷酸酶略有升高,舒张压可能也因特罗地林而升高。总之,特发性急迫性尿失禁且逼尿肌功能稳定的女性患者对治疗有反应,这与伴有已证实逼尿肌不稳定的急迫性尿失禁女性患者的情况相同。